ALTHIA HEALTH, S.L;CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
发明人:
Augusto SILVA GONZÁLEZ,José Alberto GARCÍA SANZ
申请号：
US15541846
公开号：
US20180011095A1
申请日:
2015.12.17
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention relates to the use of the monoclonal antibody NILO1 for the diagnosis, treatment and/or prevention of brain tumors and lesions. Particularly, the invention relates to methods for the diagnosis of brain tumors and brain lesions in which cells marked with said antibody, or with immunologically active fragments thereof, are detected. The invention also relates to the use of said monoclonal antibody, or immunologically active fragments thereof, as a medicament for the treatment and/or prevention of brain tumors and brain lesions. In a preferred embodiment of the invention, the monoclonal antibody NILO1, or its immunologically active fragments, are humanized.
